We accelerate the creation of safe, precise and effective antimicrobial drugs
Embedded Files
The Problem
The Problem
Thanks to burgeoning anti-microbial resistance (AMR),
by 2050,
a simple sore throat could be fatal
The global AMR crisis is projected to impact 3.8% of global GDP by 2050.
To combat this, we are replacing slow, expensive, and toxic traditional drug development
with the accelerated discovery of safe, precise and effective treatments.
A visualisation of a natural tailocin.
The Science
The Science
Conventional antibiotics are chemical poisons. Moreover, pathogens are masters of chemical evolution, learning to ignore every new drug.
Tailocins are nature's alternative: they are precision protein spikes that physically puncture pathogen membranes, like a needle popping a balloon.
Given that this is a mechanical kill, resistance is nearly impossible.
Also, because tailocins are precise, healthy cells are left completely unharmed.
At Elakistos, we bridge Microbiology and Artifical Intelligence to make these tailocins programmable. In that way, they can be programmed to attack specific pathogens.
The Solution
The Solution
Our AI-driven platform,
Elakistos Flame,
reprograms tailocin nanoparticles into
precise, safe & effective antimicrobials
Elakistos Flame (E-Flame) produces of safe, precise and effective antimicrobial designs,
ready for development by phage-based drug developers.
*We are currently raising capital to develop E-Flame into a commercially viable product.
Looking to partner with us?
Get in touch!
info@elakistosbiosciences.com
Elakistos Biosciences was one of the few AI+Biotech start-ups selected to present a tech talk at the NEXT.BIO Conference at University of California, San Francisco in October 2025. The conference was a culmination of the 2025 Next Sequence accelerator program, that Elakistos participated in.
We were one of Bpifrance EuroQuity's top deeptech start-ups selected for their April 2025 SEADE DEEPTECH E-PITCH. Watch our 5-min pitch.
We received a Fulbright grant in 2026 to accelerate the building of our AI-powered drug creation platform, E-flame. The research is conducted in collaboration with the University of Tennessee, USA.
Elakistos Biosciences was awarded the best scientific research in the National Research Fund 2024 Kenya National Research Festival Poster Category.
Page updated
Report abuse